dividend

A dividend is a cash payout that serves as a way for companies to share the profits they’ve accumulated through their operations. These payouts are drawn from earnings and cash flow paid to the shareholders of the company. Commonly these dividends are paid quarterly, although they may also be paid annually or even monthly as well. A dividend can produce as much as a quarter of your total return over long periods. Some good companies reinvest profits instead of paying a dividend. But fraudulent and failing companies hardly ever pay a dividend. So if you only buy stocks that pay dividends, you’ll automatically stay out of almost all the market’s worst stocks. For a true measure of stability, focus on companies that have maintained or raised their dividends during recessions and stock market downturns. These firms leave themselves enough room to handle periods of earnings volatility. By continually rewarding investors, and retaining enough cash to finance their businesses, they provide an attractive mix of safety, income and growth. Dividends are an important contributor to your long-term gains, and dividend-paying stocks tend to expose you to less risk than non-dividend-payers. That’s why the majority of your stocks should be dividend-payers at all times. As you get older and closer to retirement, you should raise the proportion of dividend-paying stocks in your portfolio, to cut risk and improve the stability of your investment results. To maximize your investment returns with the least risk, follow TSI Network and use our three-part Successful Investor strategy:

  1. Invest mainly in well-established companies;
  2. Spread your money out across most if not all of the five main economic sectors (Manufacturing & Industry; Resources & Commodities; Consumer; Finance; Utilities);
  3. Downplay or avoid stocks in the broker/media limelight.

Discover how to put an extra strength in your portfolio with our specific advice on how to identify high-quality dividend stocks. It’s all in our newly updated report, Dividend Paying Stocks: How High Dividend Stocks Can Supercharge Your Income Investing. And it’s yours FREE!

Read More Close
Since its founding in 1984, Cisco Systems—a leading maker of computer networking equipment—has completed a whopping 245 acquisitions. While companies that rely on acquisitions for growth make us wary, Cisco has a strong history of profitably absorbing new businesses.

The company recently announced the biggest takeover in its history—a $28-billion deal for cybersecurity software maker Splunk....
WYNDHAM HOTELS & RESORTS INC., $73.66, is still a buy. The company (symbol WH on New York) is the world’s largest hotel franchiser, with 851,000 rooms spread across 9,100 hotels in 95 countries. Its portfolio of 24 brands includes Super 8, Days Inn, Wyndham Grand, Ramada, La Quinta and Wyndham.

This week, the company rejected an unsolicited takeover offer from rival Choice Hotels International, Inc....
NUTRIEN LTD., $81.48, Toronto symbol NTR, is still a buy.

The company is the world’s largest producer of agricultural fertilizers. It took its current form on January 1, 2018, when Agrium Inc. (old symbol AGU) merged with rival Potash Corp....
PFIZER INC., $30.63, New York symbol PFE, remains a buy.

The company is one of the world’s largest makers of prescription drugs. Its top-selling brands include Enbrel (arthritis), Ibrance (breast cancer) and Prevnar (pneumonia).

Due to slowing demand for its COVID-19 products—Comirnaty (vaccine) and Paxlovid (antiviral pill)—Pfizer now expects its sales for all of 2023 will range between $58.0 billion and $61.0 billion....
BANK OF NOVA SCOTIA, $56.68, Toronto symbol BNS, is still a buy.

The bank now plans to cut 3% of its global workforce. That’s mainly because more of its customers now use the Internet and mobile platforms to manage their accounts instead of visiting a branch....
Demand for Major Drilling’s specialized services is now recovering. Meanwhile, Computer Modelling is benefiting from expanding oil and gas drilling in response to overall higher energy prices. We think there are still gains ahead for both stocks.


MAJOR DRILLING, $8.04, is a buy. This large contract driller (Toronto symbol MDI; TSINetwork: Speculative) (majordrilling.com; Shares outstanding: 83.0 million; Market cap: $667.3 million; No dividends paid) mainly serves the mining industry.


In the quarter ended July 31, 2023, revenue fell slightly, to $198.9 million from $199.8 million a year earlier....

Barrick Gold aims to keep adding to its gold production—but at the same time, it plans to keep acquiring what it sees as world-class copper assets to expand its output. We see the stock as a Power Buy.


BARRICK GOLD, $22.66, is a buy. The miner (Toronto symbol ABX; TSINetwork Rating: Average) (www.barrick.com; Shares o/s: 1.8 billion; Market cap: $40.8 billion; Dividend yield: 2.7%) is the second-largest gold producer in the world after Newmont Corp....
The coronavirus pandemic forced the cancellation of most vacation plans. However, the reopening of the economy has spurred strong demand for travel—both Wyndham, and Travel + Leisure should benefit from that surge. We see each as a buy.


WYNDHAM HOTELS & RESORTS, $74.08, is suitable for your new buying. The company (New York symbol WH; TSINetwork Rating: Extra Risk) (www.wyndhamhotels.com; Shares outstanding: 84.3 million; Market cap: $6.2 billion; Dividend yield: 1.9%) is the world’s largest hotel franchiser, with 851,000 rooms spread across 9,100 hotels in 95 countries....

EXTENDICARE INC., $6.08, is a buy. The company (Toronto symbol EXE; TSINetwork Rating: Extra Risk) (www.extendicare.com; Shares outstanding: 84.3 million; Market cap: $512.5 million; Dividend yield: 7.9%) continues to pay monthly distributions of $0.04 a share; the annual rate of $0.48 yields a very high 7.8%.



In the most recent quarter, the company’s revenue rose 3.7% in the quarter, to $307.5 million from $296.6 million a year earlier....

We continue to see attractive investment opportunities for our subscribers in top drug stocks—and that includes AbbVie Inc. At the same time, over the years, we’ve found that spinoffs are about as close as you can get to a sure thing in investing. It’s one key reason why we think AbbVie—itself a spinoff—has further gains ahead for investors. We recommend this stock as a Power Buy.


ABBVIE INC., $149.28, is a buy. The company (New York symbol ABBV; TSINetwork Rating: Above Average) (www.abbvie.com; Shares outstanding: 1.8 billion; Market cap: $268.7 billion; Dividend yield: 4.0%) was formed on January 3, 2013, when Abbott Laboratories (symbol ABT on New York) split into two publicly traded companies.


Since its spinoff from Abbott Laboratories, AbbVie has depended heavily on its Humira drug to drive both its sales and earnings....